AKT1 and gastric cancer: Network pharmacology studies suggest that naringenin, along with other flavonoids from Citri reticulatae pericarpium–Pinelliae rhizoma, could be used to treat gastric cancer by modulating PI3K–Akt and MAPK signaling pathways (Table 2), thereby regulating tumor cell proliferation, apoptosis, and vascular regeneration [135].